SAB Biotherapeutics, Inc. (SABS): SCHEDULE 13D/A filed Aug 10, 2026

Form type

SCHEDULE 13D/A

Filing date

Aug 10, 2026

Accession number

0001346824-26-000220

Filer

SAB Biotherapeutics, Inc. (CIK 1833214)